SPP1 and hepatocellular carcinoma: In the negative control group without thalidomide treatment, OPN (2.775±0.094) was highly expressed in the hepatocellular carcinoma tissues and was at a significantly higher level than that in the pericarcinomatous tissues (Table IV: F=328.74, P<0.05).